0
%
Of studies fail to meet patient recruitment deadlines
However, millions of patients visit clinical sites every day.
CT-SCOUT™ help investigators identify the ones that could benefit from a clinical study.
Clinical Trials
Mobile Application
CTMA provides French innovative digital solutions aiming at facilitating patient recruitment in clinical studies, using current patients’ conditions and powerful build-in algorithms.
Our Mission
Some numbers
The drug development landscape is increasingly complex and competitive, with a high pressure on the time to market.
Figure: Total R&D/clinical trials pipeline size, by year 2000-2022
They are so many drugs in development that it is extremely challenging to finds the way to one of them, as a patient or as a site, or to secure a high visibility on one of them for a Sponsor.
CT-SCOUTTM and ToTem4me facilitate the match between the patients and the studies.
0
%
OF THE PATIENTS WOULD WELCOME THE OPPORTUNITY TO PARTICIPATE TO A CLINICAL STUDY
Patients have become actors of their treatment conditions.
ToTem4me help them identify potential opportunities through clinical studies.
0
%
of the patients are being offered to participate to a clinical study
But 80% of patients would accept to participate t a clinical study.
CT-SCOUT™ contributes to increase the percentage of patients considered for clinical research.
0
Weeks set-up time
No more than 2 weeks are required to get CT-SCOUT™
or ToTem4me deployed for a clinical study
Our Solutions
We have customized digital solutions for the different contributors to the clinical research efforts.
CT-SCOUT™
The missing link between sponsor & sites
A multi-device application based on a unique algorithmic model to enable all physicians to quickly detect in real-time, the clinical studies running at their sites, for which a patient is potentially eligible according to his/her current health conditions.
ToTem4me
The web application for patients
A multi-device application based on a unique algorithmic model, to enable patients, with the direct support of an expert-coordinator, to quickly detect the clinical studies running in their neighborhood, for which they are potentially eligible according to their current health conditions and to inform the corresponding physicians of their potential willingness to participate.
DaaS Solution
Our teams are currently working on a Data solution, we will keep you informed shortly.
Testimonials
« CT-SCOUT™ represents a true added value to clinical research. It takes only few minutes to operate and study information is updated very quickly »
Lyon-Sud University Hospital
« CT-SCOUT™ is important for patients because it facilitates their enrolment in clinical trials. Before CT-SCOUT™ we missed out on a lot of patients and now we have dramatically increased accrual in our studies. We communicate on it and this has clearly increased our visibility at national and international levels »
ECCO Congress
Prof Laurent Peyrin-Biroulet,
Précédent
Suivant
News
You can follow CTMA on Twitter, LinkedIn, and Instagram, but here below you can find an extract of the recent company news !
CTMA is proud to announce that we have become members of the France BioTech. Click here on the link below to read …
Nous avons le Plaisir de vous annoncer que CTMA sera présente au salon MedInTech le 9 mars prochain, qui se tiendra au …
CTMA will be participating at the “ 10e Journée de Recherche Clinique” tomorrow Thursday 15th.Our CEO, Pierre Pellier will pitch for CTMA during an “Elevator …
